Proton pump inhibitors and H2 blockers reduce acid production without addressing sphincter dysfunction or tissue damage
Conclusion When it comes to treating spider veins, the choice between sclerotherapy and laser treatment depends on your specific concerns, vein size, and treatment goals
Ongoing Clinical Trials Numerous questions remain under investigation, including: Long-term biological effects Extended safety profiles Pharmacodynamic characteristics Receptor-level adaptations Combination therapy applications As a result, ongoing clinical trials continue to generate new information regarding the compounds biological activity and potential future applications
YL: Funding acquisition, Writing review & editing
Last reviewed: June 23, 2026 Last updated: June 23, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
